This description is for research context only
Wegovy and Ozempic, side-by-side A few caveats about the drugs follow, but keep in mind with the marketplace driving much of the thinking, and clinical experience evolving, there may be changes in store: Wegovy is FDA-approved for chronic weight loss management in adults 18 years of age or older with a BMI of 30 or BMI 27 and at least one medical condition related to obesity (e.g., diabetes, hypertension, etc.)
Courses available: Menopause Miniseries (Osteoporosis, Progesterone, Thyroid, Estrogen), Copper Toxicity, Mens Testosterone and more
Alzheimer's Dement
Increase dilution: For compounded tirzepatide, using a larger volume of bacteriostatic water during reconstitution creates a less concentrated solution